Bgb-15025 has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating bgb-15025, 1 is phase 1 (1 open).

Malignant solid tumor is the most common disease being investigated in bgb-15025 clinical trials [2].

Drug Details

Drug Target(s) [2]:


1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.